Lim et al. (2021) reported that a 47-year-old Malaysian woman with PD who carried homozygous PRKN mutation (p.Cys441Arg, c.1321T>C, and exon 12) showing excellent response from CASI treatment. Here, PRKN is linked to Parkinson disease.